Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000905148-25-003045
Filing Date
2025-08-18
Accepted
2025-08-18 19:27:15
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 10460
2 jfa.htm EX-1 8132
  Complete submission text file 0000905148-25-003045.txt   20517
Mailing Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119
Business Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119 702-997-5968
ALT5 Sigma Corp (Subject) CIK: 0000862861 (see all company filings)

EIN.: 411454591 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-42213 | Film No.: 251229300
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 65 E 55TH STREET 5TH FLOOR NEW YORK NY 10022
Business Address 65 E 55TH STREET 5TH FLOOR NEW YORK NY 10022 6469409426
ExodusPoint Capital Management, LP (Filed by) CIK: 0001736225 (see all company filings)

EIN.: 371875900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G